Ludwig Hantson
Director/Board Member presso HOLOGIC, INC.
Patrimonio netto: 864 732 $ in data 31/03/2024
Profilo
Ludwig N. Hantson ricopre la posizione di amministratore delegato e direttore presso Alexion Pharmaceuticals, Inc. Fa anche parte del consiglio di amministrazione di Hologic, Inc. e della Biotechnology Innovation Organization. Il dott. Hantson ha precedentemente ricoperto la posizione di presidente della divisione BioScience presso Baxter International, Inc. Amministratore Delegato di Synovis Life Technologies, Inc. e Presidente di Baxter BioScience Corp. (entrambe filiali di Baxter International, Inc.), direttore di Johnson & Johnson, presidente di Pharma Canada presso Novartis AG e amministratore delegato di Pharma North America presso Novartis Pharmaceuticals Corp. (una consociata di Novartis AG), Presidente, Amministratore delegato e Direttore di Baxalta, Inc. e Direttore di Smith & Nephew NV. Ludwig N. Hantson ha ricevuto un dottorato e una laurea presso l'Universit Catholique de Louvain.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
HOLOGIC, INC.
0.00% | 07/03/2024 | 11 092 ( 0.00% ) | 864 732 $ | 31/03/2024 |
Posizioni attive di Ludwig Hantson
Società | Posizione | Inizio |
---|---|---|
HOLOGIC, INC. | Director/Board Member | 21/11/2018 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
Precedenti posizioni note di Ludwig Hantson
Società | Posizione | Fine |
---|---|---|
ALEXION PHARMACEUTICALS, INC. | Chief Executive Officer | 21/07/2021 |
BAXALTA INC | Chief Executive Officer | 03/06/2016 |
BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/07/2015 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01/05/2010 |
NOVARTIS AG | Corporate Officer/Principal | 01/01/2010 |
Formazione di Ludwig Hantson
Université Catholique de Louvain | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
BAXTER INTERNATIONAL INC. | Health Technology |
HOLOGIC, INC. | Health Technology |
JOHNSON & JOHNSON | Health Technology |
NOVARTIS AG | Health Technology |
Aziende private | 7 |
---|---|
Synovis Life Technologies, Inc.
Synovis Life Technologies, Inc. Medical SpecialtiesHealth Technology Synovis Life Technologies, Inc. manufactures medical devices. It markets biological and mechanical products used by surgical specialties to facilitate the repair and reconstruction of soft tissue damaged or destroyed by disease or injury. The company was founded in July 1985 and is headquartered in St. Paul, MN. | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Baxalta, Inc.
Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Health Technology |
Smith & Nephew NV/SA
Smith & Nephew NV/SA Medical SpecialtiesHealth Technology Smith & Nephew NV engages in the development of medical technologies. It offers advanced wound management and advanced surgical devices. The company was founded on April 13, 2001 and is headquartered in Zaventem, Belgium. | Health Technology |
- Borsa valori
- Insiders
- Ludwig Hantson